SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001493152-18-001896
Filing Date
2018-02-13
Accepted
2018-02-12 19:45:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 88488
2 ex99-1.htm EX-99.1 9671
  Complete submission text file 0001493152-18-001896.txt   99625
Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121
Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-60385 | Film No.: 18598622
SIC: 2834 Pharmaceutical Preparations

Mailing Address 595 S FEDERAL HIGHWAY SUITE 600 BOCA RATON FL 33432
Business Address
Honig Barry C (Filed by) CIK: 0001373203 (see all company filings)

Type: SC 13D